Bandhan BSE Healthcare Index Fund Direct Growth NAV today
AMFI: 152844ISIN: INF194KB1IS2MUTF_IN: BAND_BSE_HEAL_1I1ASOLBandhan Mutual FundIndex funds
NAV ₹11.2928up ₹0.25 (2.27%)
NAV for 27 Oct 2026, against 26 Oct 2026. Declared once a day.
Other plans: Regular Growth ₹11.1004, 2.27%
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month. Assets under management in the glossary
- ₹21 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it. Total expense ratio: how it is worked out
- 0.34%22 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought. Exit load in the glossary
- 0.25%if sold within 15 days
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot pull the fund's P/E down. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted. P/E in the glossary
- 40.230 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. Riskometer in the glossary
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures. Holdings in the glossary
- 13830 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer. Launch date in the glossary
- 6 Sep 2024
Bandhan BSE Healthcare Index Fund returns
Direct Growth plan
Over each window to 27 Oct 2026
| Over | Direct GrowthTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | Regular Growth | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. Benchmark in the glossary |
|---|---|---|---|
| 1 week | +2.39% | +2.37% | – |
| 1 month | −5.23% | −5.30% | – |
| 3 months | −2.57% | −2.77% | – |
| 6 months | +9.62% | +9.18% | – |
| 1 year | +9.17% | +8.30% | +16.77%to 30 Sep 2026 |
| 3 years | Needs 3 years | – | – |
₹10,000 put in on 9 Sep 2024 is ₹11,326 at the NAV of 27 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load. Growth of ₹10,000 in the glossaryOver a year and longer, a return is the yearly rate. Benchmark: BSE Healthcare TRI, over the same days as the fund, or to the month end its cell names.
At the month end, 30 Sep 2026
| Over | Fund | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. Benchmark return in the glossary |
|---|---|---|
| 1 year | +15.42% | +16.77% |
| Since launch | +6.58% | +7.77% |
Benchmark: BSE Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- Fund, Direct GrowthCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- Loss
Bandhan BSE Healthcare Index Fund SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 27 Oct 2026SIP calculator
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. Amount invested in the glossary | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. Value today in the glossary | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. SIP return (XIRR) in the glossary | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. SIP return after stamp duty in the glossary | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. Stamp duty paid in the glossary |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,28,226₹1,28,220 after stamp duty | +13.25% | +13.24% | ₹6 | |
| Since Sep 202425 instalments | ₹2,50,000 | ₹2,76,757₹2,76,743 after stamp duty | +9.81% | +9.81% | ₹13 |
3 years: Launched 6 Sep 2024, needs 3 years of history.
A SIP that rises every year: Step-up SIP calculator
Rolling returns
Per cent a year, every window from 9 Sep 2024 to 27 Oct 2026
Lowest to highestAverage
LowestLowest rolling return. The lowest yearly return of any window of this length in the fund's history, one window starting on each day it priced. Lowest rolling return in the glossaryAverageAverage rolling return. The average of the yearly returns of every window of this length in the fund's history. Average rolling return in the glossaryHighestHighest rolling return. The highest yearly return of any window of this length in the fund's history. Highest rolling return in the glossaryEnded higherWindows that ended higher. The share of all the windows of this length in which the NAV ended above where it started. Windows that ended higher in the glossary
1 year283 windows−4.0%+6.9%+19.1%84.5%
3 yearsLaunched 6 Sep 2024, needs 4 years of history
Tracking error
Against BSE Health Care - TRI, as on 30 Sep 2026.
Against its index, by window
| Measure | Direct, this plan | Regular |
|---|---|---|
| Tracking errorTracking error. How much an index fund's daily returns differed from its index's, stated as a yearly figure. Tracking error in the glossary | 0.04% | 0.06% |
| Difference, 1 yearTracking difference. The index fund's return less its index's return over the same period; the fund's costs make it negative. Tracking difference in the glossary | −3.19 pts | −4.12 pts |
| Difference since launch | −1.62 pts | −2.47 pts |
Difference: the fund's return less the index's, in percentage points.
Bandhan BSE Healthcare Index Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio. Direct and regular plan cost gap in the glossary
- 0.81 ptsA year, on 22 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies. Expense ratio, 30-day average in the glossary
- 0.35%Over the last 30 days filed
- Regular, 30-day average
- 1.15%Over the last 30 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan highest 0.36%, Sep 2026.Direct plan lowest 0.21%, Jul 2025.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. Base expense ratio in the glossary | 0.19% | 0.88% |
| Brokerage | 0.01% | 0.01% |
| Transaction costs | None | None |
| Statutory levies | 0.14% | 0.26% |
Per cent of assets a year, filed for 22 Oct 2026. The parts add up to that day's total.
Exit load, in the fund house's words
• 0.25% - if redeemed on or before 15 days from the allotment date. • Nil – if redeemed after 15 days from the allotment date
Buying and selling
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase. Minimum investment in the glossary
- ₹1,000
- Minimum top-up
- ₹1,000
- Minimum redemption
- ₹500
- SIP
- Accepted
- SIP minimum
- ₹100
- SIP instalments, at least
- 6
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold. Lock-in in the glossary
- None
- SIP dates
- Monthly - Investor may choose any day of the month from 1st to 31st as the date of the instalment and Quarterly -Investor may choose any day of the month from 1st to 31st as the date of the instalment
As listed for this plan on 27 Oct 2026.
Bandhan BSE Healthcare Index Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹22 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors. Share of assets in the direct plans in the glossary
- 54.6%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Sep 2024.
Assets at each month end
Highest ₹24 Cr, Jul 2026.Lowest ₹16 Cr, Jan 2026.
Bandhan BSE Healthcare Index Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. Large, mid and small cap in the glossary | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. Weight in the fund in the glossary | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. Held since in the glossary | |||
|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | Large cap13th | 12.36% | 2.58 | 14,182 | Sep 2024or earlier |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | Large cap50th | 7.44% | 1.55 | 1,674 | Sep 2024or earlier |
| Apollo Hospitals EnterpriseHealthcare Services | Large cap97th | 5.23% | 1.09 | 1,341 | Sep 2024or earlier |
| Laurus LabsPharmaceuticals & Biotechnology | Mid cap171st | 4.85% | 1.01 | 5,110 | Sep 2024or earlier |
| CiplaPharmaceuticals & Biotechnology | Large cap99th | 4.80% | 1.00 | 7,428 | Sep 2024or earlier |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | Mid cap104th | 4.74% | 0.99 | 8,003 | Sep 2024or earlier |
| Max Healthcare InstituteHealthcare Services | Mid cap111th | 4.33% | 0.90 | 9,716 | Sep 2024or earlier |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | Large cap61st | 3.56% | 0.74 | 1,549 | Sep 2024or earlier |
| LupinPharmaceuticals & Biotechnology | Mid cap105th | 3.11% | 0.65 | 3,183 | Sep 2024or earlier |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Mid cap138th | 2.90% | 0.60 | 3,628 | Sep 2024or earlier |
| Fortis HealthcareHealthcare Services | Mid cap156th | 2.52% | 0.53 | 6,843 | Sep 2024or earlier |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | Mid cap176th | 2.17% | 0.45 | 1,965 | Sep 2024or earlier |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | Mid cap164th | 1.90% | 0.40 | 770 | Sep 2024or earlier |
| Zydus LifesciencesPharmaceuticals & Biotechnology | Mid cap114th | 1.83% | 0.38 | 3,276 | Sep 2024or earlier |
| Mankind PharmaPharmaceuticals & Biotechnology | Mid cap119th | 1.76% | 0.37 | 1,465 | Sep 2024or earlier |
Weight is per cent of the fund's net assets; value in ₹ crore. 2 lines filed with no weight are listed without one.
Cash and receivables on 30 Sep 2026
| Net Current Assets | −0.45% | −0.09 |
| Triparty Repo TRP_011026 | 0.28% | 0.06 |
| Cash Margin - CCIL | – | 0.00 |
Weight is per cent of the fund's net assets; value in ₹ crore. 2 lines filed with no weight are listed without one.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions. Largest holding in the glossary
- 12.36%Sun Pharmaceutical Industries
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions. Top 5 holdings in the glossary
- 34.68%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions. Top 10 holdings in the glossary
- 53.32%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights. Effective number of holdings in the glossary
- 24.9Taken over 100.17% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought. Asset allocation in the glossary- Indian shares100.17%
- Cash and receivables−0.17%
Per cent of the fund's net assets.
Large, mid and small cap
- Large cap33.33%
- Mid cap38.51%
- Small cap28.15%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets. Sector weight in the glossary1sector
- Healthcare100.17%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare138 companies | 100.17% | 100.12% | 99.93% | 100.02% | 100.24% | 100.04% | 100.01% | 100.07% | 100.16% | 100.00% | 100.00% | 100.88% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before. New positions in the glossary
- 160.62% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date. Sold out in the glossary
- 30.03% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth. Added to in the glossary
- 114
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth. Trimmed in the glossary
- 7
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price. Unchanged in the glossary
- 1
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month. Traded at least in the glossary
- 0.03%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it. Weight that moved in the glossary
- 3.84%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). What changed in the glossary | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. Change in weight in the glossary | ||||
|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Trimmed | 3.56% | 4.36% | −0.80 pts | −293 |
| Sun Pharmaceutical Industries | Added | 12.36% | 12.95% | −0.59 pts | +268 |
| Dr. Reddy's Laboratories | Added | 4.74% | 4.35% | +0.39 pts | +151 |
| Fortis Healthcare | Added | 2.52% | 2.90% | −0.38 pts | +130 |
| Laurus Labs | Added | 4.85% | 4.48% | +0.37 pts | +170 |
| Apollo Hospitals Enterprise | Added | 5.23% | 5.55% | −0.32 pts | +25 |
| Rubicon Research | Added | 0.67% | 0.35% | +0.32 pts | +466 |
| Max Healthcare Institute | Added | 4.33% | 4.62% | −0.29 pts | +184 |
| Divi's Laboratories | Added | 7.44% | 7.22% | +0.22 pts | +32 |
| Anthem Biosciences | Trimmed | 0.58% | 0.77% | −0.19 pts | −404 |
| CORONA Remedies | Added | 0.25% | 0.08% | +0.17 pts | +170 |
| Wockhardt | Added | 1.10% | 0.96% | +0.14 pts | +21 |
| Biocon | Added | 1.64% | 1.77% | −0.13 pts | +14 |
| Lupin | Added | 3.11% | 3.24% | −0.13 pts | +60 |
| Emcure Pharmaceuticals | Added | 0.51% | 0.39% | +0.12 pts | +108 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries | 13.22%Added | 14.10%Cut | 13.42%Cut | 13.21%Cut | 13.49%Cut | 14.45%Added | 13.92%Added | 13.25%Added | 12.90%Cut | 13.35%Added | 12.95%Cut | 12.36%Added |
 Divi's Laboratories | 6.37%Added | 6.02%Cut | 6.02%Cut | 6.05%Cut | 6.01%Cut | 5.77%Cut | 5.91%Added | 5.78%Added | 5.37%Cut | 6.38%Added | 7.22%Cut | 7.44%Added |
 Apollo Hospitals Enterprise | 5.73%Added | 5.38%Cut | 5.31%Cut | 5.57%Cut | 5.87%Cut | 5.78%Cut | 5.56%Added | 5.69%Added | 5.69%Cut | 5.68%Added | 5.55%Cut | 5.23%Added |
 Laurus Labs | 2.75%Added | 2.92%Cut | 3.18%Cut | 2.94%Cut | 3.07%Cut | 2.94%Cut | 3.05%Added | 3.61%Added | 3.73%Cut | 4.33%Added | 4.48%Cut | 4.85%Added |
 Cipla | 6.20%Added | 6.22%Cut | 6.31%Cut | 5.87%Cut | 5.60%Cut | 5.27%Cut | 5.28%Added | 5.39%Added | 5.31%Cut | 5.18%Added | 4.91%Cut | 4.80%Added |
 Dr. Reddy's Laboratories | 5.41%Added | 5.59%Cut | 5.72%Cut | 5.82%Cut | 5.77%Cut | 5.82%Cut | 5.75%Added | 5.41%Added | 5.30%Cut | 4.35%Added | 4.35%Cut | 4.74%Added |
 Max Healthcare Institute | 6.29%Added | 6.27%Cut | 5.70%Cut | 5.55%Cut | 5.93%Cut | 5.42%Cut | 5.24%Added | 4.86%Added | 5.36%Cut | 5.05%Added | 4.62%Cut | 4.33%Added |
 Torrent Pharmaceuticals | 2.77%Added | 2.85%Cut | 2.98%Cut | 3.26%Cut | 3.35% | 3.26%Cut | 3.04%Added | 3.04%Added | 3.01%Cut | 4.53%Added | 4.36%Cut | 3.56%Cut |
 Lupin | 3.52%Added | 3.67%Cut | 3.78%Cut | 4.08%Cut | 4.10%Cut | 4.27%Cut | 3.98%Added | 3.75%Added | 3.76%Cut | 3.64%Added | 3.24%Cut | 3.11%Added |
 Aurobindo Pharma | 2.35%Added | 2.49%Cut | 2.43%Cut | 2.65%Cut | 2.50%Cut | 2.77%Cut | 2.76%Added | 2.72%Added | 2.82%Cut | 2.74%Added | 2.89%Cut | 2.90%Added |
 Fortis Healthcare | 3.95%Added | 3.49%Cut | 3.40%Cut | 3.48%Cut | 3.61%Cut | 3.15%Cut | 3.43%Added | 3.30%Added | 3.20%Cut | 3.06%Added | 2.90%Cut | 2.52%Added |
 Glenmark Pharmaceuticals | 2.10%Added | 2.12%Cut | 2.25%Cut | 2.37%Cut | 2.35%Cut | 2.43%Cut | 2.57%Added | 2.32%Added | 2.11%Cut | 2.08%Added | 2.28%Cut | 2.17%Added |
 Alkem Laboratories | 2.29%Added | 2.33%Cut | 2.38%Added | 2.61%Cut | 2.43% | 2.37%Cut | 2.26%Added | 2.19%Added | 2.09%Cut | 2.09%Added | 1.92%Cut | 1.90%Added |
 Zydus Lifesciences | 1.82%Added | 1.73%Cut | 1.70%Cut | 1.75%Cut | 1.71%Cut | 1.67%Cut | 1.60%Added | 1.85%Added | 1.79%Cut | 1.76%Added | 1.79%Cut | 1.83%Added |
 Mankind Pharma | 1.97%Added | 1.83%Cut | 1.81%Cut | 1.86%Cut | 1.84%Cut | 1.70%Cut | 1.79%Added | 1.81%Added | 1.82%Cut | 1.71%Added | 1.64%Cut | 1.76%Added |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it. Portfolio turnover in the glossary
Highest 32.0% in Mar 2026
Risk ratios
NAV to 27 Oct 2026
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves. Standard deviation in the glossary15.20%
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure. Downside deviation in the glossary8.77%
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV. Sharpe ratio in the glossary0.73
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down. Sortino ratio in the glossary1.15
Against BSE Healthcare TRI
BetaBeta. How much the fund's monthly return moved for each 1% move in its benchmark: 1 moves with it, below 1 moves less. Beta in the glossary1.01
R-squaredR-squared. The share of the fund's monthly movement that its benchmark's movement explains, from 0 to 100. R-squared in the glossary100.0
CorrelationCorrelation. How closely the fund's monthly returns moved in step with its benchmark's, from minus 1 (always opposite) to 1 (always together). Correlation in the glossary1.00
Upside captureUpside capture. The fund's return in the months its benchmark rose, as a percentage of the benchmark's return in those months. Upside capture in the glossary100.8%
Downside captureDownside capture. The fund's return in the months its benchmark fell, as a percentage of the benchmark's fall in those months. Downside capture in the glossaryNeeds 6 falling months
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. Largest fall in the glossary | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. Back at the high in the glossary |
|---|---|---|---|---|
| 1 year | −9.97% | 23 Sep 2026 | 23 Oct 2026 | Not yet |
| Since Sep 2024 | −16.18% | 2 Jan 2025 | 28 Feb 2025 | 29 Jul 2025 |
Risk level by month
| Months | Fund | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. Benchmark's risk level in the glossary |
|---|---|---|
| Feb 2025 to Aug 202619 months | Very High | Very HighBSE Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Bandhan BSE Healthcare Index Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. Return in the manager's time in the glossary | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. Benchmark over the same days in the glossary | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. Difference from the benchmark in the glossary | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. Portfolio changed after the handover in the glossary | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. Portfolio changed before the handover in the glossary | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. Assets the manager runs in the glossary | ||
|---|---|---|---|---|---|---|---|---|
| Abhishek JainPrimary | Mar 2025 | +13.22%a year | – | – | 3.8% | 4.3% | 23 | ₹6,336 Cr₹765 Cr alone |
| Mayuresh NagvekarComanage | Feb 2026 | +10.86%over 251 days | – | – | 5.2% | 4.6% | 19 | ₹5,571 Cr |
Returns are the direct plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | |||||
|---|---|---|---|---|---|
| Bandhan Nifty 50 Index FundAbhishek Jain | Mar 2025 | +1.87%a year | +2.02% | −0.15 pts | ₹2,687 Cr |
| Bandhan Nifty100 Low Volatility 30 Index FundAbhishek Jain | Mar 2025 | +2.74%a year | +3.26% | −0.51 pts | ₹1,428 Cr |
| Bandhan Nifty Alpha 50 Index FundAbhishek Jain | Mar 2025 | +9.74%a year | +11.36% | −1.61 pts | ₹594 Cr |
| Bandhan Silver ETFAbhishek Jain | Dec 2025 | – | – | – | ₹263 Cr |
| Bandhan Nifty 100 Index FundAbhishek Jain | Mar 2025 | +3.00%a year | +3.18% | −0.18 pts | ₹262 Cr |
| Bandhan Gold ETFAbhishek Jain | Dec 2025 | – | – | – | ₹186 Cr |
| Bandhan Nifty 50 Index FundMayuresh Nagvekar | Feb 2026 | −10.88%over 251 days | −10.78% | −0.10 pts | ₹2,687 Cr |
| Bandhan Nifty100 Low Volatility 30 Index FundMayuresh Nagvekar | Feb 2026 | −9.63%over 251 days | −9.30% | −0.33 pts | ₹1,428 Cr |
| Bandhan Nifty Alpha 50 Index FundMayuresh Nagvekar | Feb 2026 | −0.22%over 251 days | +1.23% | −1.45 pts | ₹594 Cr |
| Bandhan Nifty 100 Index FundMayuresh Nagvekar | Feb 2026 | −9.73%over 251 days | −9.61% | −0.11 pts | ₹262 Cr |
The ten largest by assets, by manager. Returns are the direct plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in the underlying securities in the same proportion, subject to tracking error. The BSE Healthcare Index will track the performance of companiesthat are part of BSE AllCap belonging to the Healthcare sector.
Asset allocation
- Securities belonging to the Bandhan BSE Healthcare Index (including stock and index derivatives) - 95% - 100%
- Debt & Money Market instruments - 0%- 5%
Type of scheme
An open-ended scheme tracking BSE Healthcare Index
- Benchmark
- BSE Healthcare TRI
- Risk level at launch
- Very High
- New fund offer
- 21 Aug 2024 to 3 Sep 2024
- Units first allotted
- 6 Sep 2024
- Open for sale again
- 9 Sep 2024
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹1,000
Plans and codes
| Plan | AMFI code | ISIN | MUTF_IN | First NAV |
|---|---|---|---|---|
| Direct Growth | 152844 | INF194KB1IS2 | BAND_BSE_HEAL_1I1ASOL | 9 Sep 2024 |
| Regular Growth | 152843 | INF194KB1IR4 | BAND_BSE_HEAL_4BIXLH | 9 Sep 2024 |
This fund
- Scheme information documentThe fund's objective, terms, costs and risks in full
Factsheet
- October 2026Bandhan Mutual Fund, Sep 2026
- Passive Factsheet - October - 2026Bandhan Mutual Fund, Sep 2026
Statement of additional information
- SAI Bandhan Mutual FundBandhan Mutual Fund, Oct 2026
Annual report
- Abridged Annual Report - Set 1 - Debt SchemesBandhan Mutual Fund, Mar 2026
- Abridged Annual Report - Set 2 - Equity SchemesBandhan Mutual Fund, Mar 2026
- Abridged Annual Report - Set 3 - Fixed Term PlansBandhan Mutual Fund, Mar 2026
- Abridged Annual Report - Set 4 - Fund of Funds SchemesBandhan Mutual Fund, Mar 2026
Riskometer disclosure
- Annual changes in Risk-o-meterBandhan Mutual Fund, Mar 2026
Portfolio overlap disclosure
- Portfolio Overlap - 30-Sep-2026Bandhan Mutual Fund, Sep 2026